Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patients

por Hansen, S, Overgaard, J, Rose, C, Knoop, Ann, Lænkholm, A-V, Andersen, J, Sørensen, F B, Andreasen, P A
Publicado 2003

Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.

por Knoop, A., Andreasen, P. A., Andersen, J. A., Hansen, S., Laenkholm, A. V., Simonsen, A. C., Andersen, J., Overgaard, J., Rose, C.
Publicado 1998